Showing results (221-230 of 595) with videos related to
Sort By:
Pageof 60
RMD Open|July 28, 2023
Patient-level factors predictive of interstitial lung disease in rheumatoid arthritis: a systematic reviewEric L Matteson, Marco Matucci-Cerinic, Michael Kreuter, et al.Arthritis Research & Therapy|September 12, 2023
Arsenic trioxide demonstrates efficacy in a mouse model of preclinical systemic sclerosisAnne Cauvet, Arthur Decellas, Christophe Guignabert, et al.The Journal of Rheumatology|July 18, 2008
Osteoarticular involvement in a series of 100 patients with sarcoidosis referred to rheumatology departmentsNatacha Thelier, Noémie Assous, Chantal Job-Deslandre, et al.The Journal of Rheumatology|October 3, 2014
Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patientsJudith Payet, Claire Goulvestre, Lisa Bialé, et al.Journal of Scleroderma and Related Disorders|February 9, 2024
Deficiency and altered phenotype of mucosal-associated invariant T cells in systemic sclerosisManon Lesturgie-Talarek, Virginie Gonzalez, Lucie Beaudoin, et al.International Journal of Molecular Sciences|February 25, 2023
Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial HypertensionBeatrice Moccaldi, Laura De Michieli, Marco Binda, et al.Rheumatology (Oxford, England)|May 22, 2024
Systemic sclerosis sine scleroderma is more aggressive in children than in adultsFrancesca Tirelli, Elisabetta Zanatta, Beatrice Moccaldi, et al.International Journal of Molecular Sciences|February 25, 2023
Size-Exclusion Chromatography Combined with Ultrafiltration Efficiently Isolates Extracellular Vesicles from Human Blood Samples in Health and DiseaseChiara Franco, Anna Ghirardello, Loris Bertazza, et al.Journal of Clinical Medicine|September 14, 2024
Cocaine- and Levamisole-Induced Vasculitis: Defining the Spectrum of Autoimmune ManifestationsLuca Iorio, Federica Davanzo, Diego Cazzador, et al.Clinical Rheumatology|August 28, 2024
Effectiveness and safety of low dose Rituximab as remission-maintenance treatment for patients with refractory idiopathic inflammatory myopathies: results of a retrospective study from a monocentric cohortAnna Gamba, Roberto Depascale, Elisabetta Zanatta, et al.Pageof 60